@Article{info:doi/10.2196/resprot.7750,
author="Hess, Lisa M
and Kern, David M
and Carter, Gebra Cuyun
and Wang, Liya
and Winfree, Katherine
and Cui, Zhanglin Lin
and Sontag, Angelina
and Oton, Ana B",
title="Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol",
journal="JMIR Res Protoc",
year="2017",
month="Oct",
day="11",
volume="6",
number="10",
pages="e195",
keywords="cancer; non-small cell lung cancer; chemotherapy; regimen; line of therapy; treatment sequence; progression-free survival; overall survival; real-world data",
abstract="Background: Survival outcomes are related to treatment choices in a line of therapy and to treatment sequences across all lines of therapy. Objective: The Real-World Treatment Sequences and Outcomes among Patients with NSCLC (RESOUNDS) study is designed to (1) evaluate treatment sequences used for patients who receive at least two lines of therapy for non-small cell lung cancer (NSCLC) in the United States and (2) evaluate patient outcomes in terms of progression-free and overall survival related to treatment sequencing. Additional objectives include the evaluation of symptoms, comorbidities, and health care resource utilization and costs. Methods: Patients will be censored at loss to follow-up due to leaving the health plan or reaching the end of the study period. Results: This study is ongoing. Conclusions: The RESOUNDS cohort study is a novel approach to building a comprehensive dataset that mimics a prospective observational study using linked patient-level data from four real-world data sources. This study will provide timely information on the sequencing of treatments for patients with NSCLC. ",
issn="1929-0748",
doi="10.2196/resprot.7750",
url="http://www.researchprotocols.org/2017/10/e195/",
url="https://doi.org/10.2196/resprot.7750"
}